Approvals/TGA/NELARABINE-REACH nelarabine 250 mg/50 mL solution for infusion vial

Approved

STANDARD

NELARABINE-REACH nelarabine 250 mg/50 mL solution for infusion vial

Reach Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 4e1d5840ea427714
Product Name: NELARABINE-REACH nelarabine 250 mg/50 mL solution for infusion vial
Artg Id: 405072
Artg Name: NELARABINE-REACH nelarabine 250 mg/50 mL solution for infusion vial
Sponsor: Reach Pharmaceuticals Pty Ltd
Company Detail Path: /organization/reach-pharmaceuticals-pty-ltd
Artg Date: 2024-04-03
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/cf9e0e438da2624c17139996755fe108.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/9abd5fcc86d41b243ab8927b95a8ef45.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

4e1d5840ea427714

Type

Standard